These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25409115)

  • 1. The health technology assessment of the compulsory accident insurance scheme of hand transplantation in Switzerland.
    Brügger U; Plessow R; Hess S; Caballero A; Eichler K; Meyer V; von Wartburg U
    J Hand Surg Eur Vol; 2015 Nov; 40(9):914-23. PubMed ID: 25409115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on The health technology assessment of the compulsory accident insurance scheme of hand transplantation in Switzerland. Brügger et al. J Hand Surg Eur. 2015, 40: 914-23.
    Kay S; Wilks DJ; Bellew M; Baker R
    J Hand Surg Eur Vol; 2015 Nov; 40(9):924-6. PubMed ID: 26494908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical statistics in compulsory accident insurance].
    Fasler S
    Soz Praventivmed; 1981 Dec; 26(6):384-6. PubMed ID: 7331527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Private accident insurance in Switzerland with reference to liability insurance as a part of social security].
    Richner C
    Z Unfallchir Versicherungsmed; 1991; 84(2):72-5. PubMed ID: 1768527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Managed health care: scope, concept and strategic management potentials from the viewpoint of the Swiss Accident Insurance Fund].
    Bapst L
    Swiss Surg; 1996; 2(4):154-62. PubMed ID: 9312392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond.
    Rocchi A; Menon D; Verma S; Miller E
    Value Health; 2008; 11(4):771-83. PubMed ID: 18179658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statutory accident insurance--obligatory social accident insurance in Switzerland].
    Ramseier EW
    Z Unfallchir Versicherungsmed; 1991; 84(2):76-83. PubMed ID: 1768528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of Occupational Injuries Related to Hands: Calculation of Subsequent Injury Costs for the Austrian Social Occupational Insurance Institution (AUVA)].
    Rauner MS; Mayer B; Schaffhauser-Linzatti MM
    Handchir Mikrochir Plast Chir; 2015 Aug; 47(4):228-34. PubMed ID: 26287325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Authority for Health: France.
    Rochaix L; Xerri B
    Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure of the Federal Office for Social Insurance. Listing of the basic laws and providing disability insurance].
    Bugnion JP
    Schweiz Rundsch Med Prax; 1986 Mar; 75(13):353-6. PubMed ID: 3961344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statistics of obligatory accident insurance--a contribution to health statistics in Switzerland].
    Wüthrich P
    Soz Praventivmed; 1984; 29(6):273-5. PubMed ID: 6516589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012.
    Brügger U; Ruckstuhl A; Horisberger B; Gratwohl A
    Int J Technol Assess Health Care; 2014 Jul; 30(3):253-9. PubMed ID: 25100035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug reimbursement decision-making in Thailand, China, and South Korea.
    Ngorsuraches S; Meng W; Kim BY; Kulsomboon V
    Value Health; 2012; 15(1 Suppl):S120-5. PubMed ID: 22265058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.
    Gandjour A
    Appl Health Econ Health Policy; 2011 Mar; 9(2):65-71. PubMed ID: 21332250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shaft fractures in childhood. Insurance problems from the viewpoint of liability].
    Richner C
    Z Unfallchir Versicherungsmed Berufskr; 1989; 82(4):261-3. PubMed ID: 2516944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decision of the Federal Joint Committee on screening for chorionicity - benefit assessment in the absence of screening studies].
    Schwalm A; Bertelsmann H; Gruber S; Wietschel G; Matthias K
    Gesundheitswesen; 2013 Jan; 75(1):13-21. PubMed ID: 22847814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.